Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
JPMorgan Chase & Co. and its affiliates have become a substantial holder in Telix Pharmaceuticals Ltd, acquiring a 5.04% voting power with 16,881,167 ordinary shares. This position was reached on July 24, 2024, as detailed in a recent notice that outlines the nature and extent of JPMorgan’s relevant interests and associated entities.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
